Antonio A Bon-Nieves, Naomi C Wang, Sarah F Wagoner, Rahul Alapati, Maria Feucht, Uma Ramesh, Rohit Nallani, Emma Rea, Colleen Sommer, Amelia S Lawrence, Kevin J Sykes, Kiran Kakarala, Yelizaveta Shnayder, Andrés M Bur, Chelsea S Hamill
{"title":"Impact of Presurgical Second-Touch Visits on Delays in Initiating Adjuvant Radiation Therapy.","authors":"Antonio A Bon-Nieves, Naomi C Wang, Sarah F Wagoner, Rahul Alapati, Maria Feucht, Uma Ramesh, Rohit Nallani, Emma Rea, Colleen Sommer, Amelia S Lawrence, Kevin J Sykes, Kiran Kakarala, Yelizaveta Shnayder, Andrés M Bur, Chelsea S Hamill","doi":"10.1002/ohn.1194","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Patients with head and neck squamous cell carcinoma (HNSCC) often encounter delays in starting postoperative radiotherapy (PORT), leading to worse outcomes. We investigated whether attending second-touch visits-appointments after the initial clinic visit and before surgery to address treatment-related questions and follow-up expectations-with an advanced practice provider (APP) is associated with reduced PORT delays.</p><p><strong>Study design: </strong>Retrospective cohort study.</p><p><strong>Setting: </strong>Single tertiary referral center.</p><p><strong>Methods: </strong>Adult patients with HNSCC who underwent free flap surgery and PORT between 2020 and 2022 were included. All patients were offered a second-touch visit. The primary outcome was PORT delay, defined as treatment initiation >42 days after surgery. Clinicodemographic and treatment-related data were collected at baseline and at the last known follow-up.</p><p><strong>Results: </strong>Of the 104 patients included, 57.7% attended a second-touch visit. Attendance was associated with receiving radiotherapy (RT) in an academic setting (65.0% vs 40.9%, P = .015) and fewer PORT delays (56.7% vs 79.5%, P = .015). Multivariable analysis revealed a 70% reduction in odds of PORT delay for those attending second-touch visits (adjusted odds ratio [aOR] = 0.298, 95% CI 0.103-0.866, P = .026). PORT delay was more likely in patients with RT in a community setting (aOR = 3.783, 95% CI 1.284-11.146, P = .016), wound complications (aOR = 5.149, 95% CI 1.363-19.460, P = .016), and a higher comorbidity index (aOR = 1.407, 95% CI 1.012-1.957, P = .042).</p><p><strong>Conclusion: </strong>Attendance of a second-touch visit and RT at a tertiary medical center significantly reduced the likelihood of PORT delay. These findings underscore the importance of APP-driven patient navigation in improving timely care and outcomes for patients with HNSCC.</p>","PeriodicalId":19707,"journal":{"name":"Otolaryngology- Head and Neck Surgery","volume":" ","pages":""},"PeriodicalIF":2.6000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Otolaryngology- Head and Neck Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ohn.1194","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OTORHINOLARYNGOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: Patients with head and neck squamous cell carcinoma (HNSCC) often encounter delays in starting postoperative radiotherapy (PORT), leading to worse outcomes. We investigated whether attending second-touch visits-appointments after the initial clinic visit and before surgery to address treatment-related questions and follow-up expectations-with an advanced practice provider (APP) is associated with reduced PORT delays.
Study design: Retrospective cohort study.
Setting: Single tertiary referral center.
Methods: Adult patients with HNSCC who underwent free flap surgery and PORT between 2020 and 2022 were included. All patients were offered a second-touch visit. The primary outcome was PORT delay, defined as treatment initiation >42 days after surgery. Clinicodemographic and treatment-related data were collected at baseline and at the last known follow-up.
Results: Of the 104 patients included, 57.7% attended a second-touch visit. Attendance was associated with receiving radiotherapy (RT) in an academic setting (65.0% vs 40.9%, P = .015) and fewer PORT delays (56.7% vs 79.5%, P = .015). Multivariable analysis revealed a 70% reduction in odds of PORT delay for those attending second-touch visits (adjusted odds ratio [aOR] = 0.298, 95% CI 0.103-0.866, P = .026). PORT delay was more likely in patients with RT in a community setting (aOR = 3.783, 95% CI 1.284-11.146, P = .016), wound complications (aOR = 5.149, 95% CI 1.363-19.460, P = .016), and a higher comorbidity index (aOR = 1.407, 95% CI 1.012-1.957, P = .042).
Conclusion: Attendance of a second-touch visit and RT at a tertiary medical center significantly reduced the likelihood of PORT delay. These findings underscore the importance of APP-driven patient navigation in improving timely care and outcomes for patients with HNSCC.
目的:头颈部鳞状细胞癌(HNSCC)患者术后放疗(PORT)开始延迟,导致预后较差。我们调查了与高级执业医师(APP)进行第二次接触访问是否与减少PORT延迟有关。第二次接触访问是指在初次门诊访问后和手术前进行预约,以解决与治疗相关的问题和随访期望。研究设计:回顾性队列研究。环境:单一三级转诊中心。方法:纳入2020 - 2022年间接受游离皮瓣手术和PORT的成年HNSCC患者。所有患者都被提供了第二次接触访问。主要终点为PORT延迟,定义为手术后42天开始治疗。在基线和最后一次已知随访时收集临床人口学和治疗相关数据。结果:在纳入的104例患者中,57.7%的患者参加了第二次触诊。出席率与在学术环境中接受放疗(RT)相关(65.0% vs 40.9%, P = 0.015), PORT延迟较少(56.7% vs 79.5%, P = 0.015)。多变量分析显示,参加第二次就诊的患者PORT延迟的几率降低了70%(校正优势比[aOR] = 0.298, 95% CI 0.103-0.866, P = 0.026)。在社区环境中接受RT治疗的患者更有可能出现PORT延迟(aOR = 3.783, 95% CI 1.384 -11.146, P = 0.016)、伤口并发症(aOR = 5.149, 95% CI 1.363-19.460, P = 0.016)以及更高的合病指数(aOR = 1.407, 95% CI 1.012-1.957, P = 0.042)。结论:在三级医疗中心参加第二次接触访问和RT可显著降低PORT延迟的可能性。这些发现强调了app驱动的患者导航在改善HNSCC患者及时护理和预后方面的重要性。
期刊介绍:
Otolaryngology–Head and Neck Surgery (OTO-HNS) is the official peer-reviewed publication of the American Academy of Otolaryngology–Head and Neck Surgery Foundation. The mission of Otolaryngology–Head and Neck Surgery is to publish contemporary, ethical, clinically relevant information in otolaryngology, head and neck surgery (ear, nose, throat, head, and neck disorders) that can be used by otolaryngologists, clinicians, scientists, and specialists to improve patient care and public health.